ISR Immune System Regulation Holding Overview

  • Status
  • Public
  • Employees
  • 2
Employees
  • Stock Symbol
  • ISR
Stock Symbol
  • Share Price
  • $0.65
  • (As of Tuesday Closing)

ISR Immune System Regulation Holding General Information

Description

ISR Immune System Regulation Holding AB is a Sweden based company is engaged in research within the area of immunotherapy. It is principally focused on preclinical and clinical research with the objective to develop novel drugs for curative treatments of viral infections. The group is focused on developing ISR048 technology for the novel treatment of viral infected patients with a focus on human immunodeficiency virus (HIV) infection.

Contact Information

Website
www.israb.se
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
STO
Primary Office
  • Rörstrandsgatan 58
  • 113 40 Stockholm
  • Sweden
+46 070-299 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ISR Immune System Regulation Holding Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.65 $0.75 $0.39 - $1.07 $39.5M 60.8M 1.17M -$0.14

ISR Immune System Regulation Holding Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 22,314 22,314 12,237 10,127
Revenue 0 0 0 0
EBITDA (3,243) (3,243) (3,054) (2,377)
Net Income (3,370) (3,370) (3,074) (2,418)
Total Assets 4,891 4,891 2,521 3,775
Total Debt 0 0 64 58
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ISR Immune System Regulation Holding Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ISR Immune System Regulation Holding‘s full profile, request access.

Request a free trial

ISR Immune System Regulation Holding Executive Team (4)

Name Title Board Seat Contact Info
Ola Winqvist Ph.D VD, Chief Scientific Officer & Chief Executive Officer
Mikael Bronnegard Ph.D Chief Executive Officer
Gunnar Modalen Chief Financial Officer
Lennart Dreyer Ph.D Chief Compliance Officer
To view ISR Immune System Regulation Holding’s complete executive team members history, request access »

ISR Immune System Regulation Holding Board Members (1)

Name Representing Role Since
000000 00000000 ISR Immune System Regulation Holding Co-Founder & Board Member 000 0000
To view ISR Immune System Regulation Holding’s complete board members history, request access »

ISR Immune System Regulation Holding Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial